Literature DB >> 1478367

Effects of C-peptide on blood flow, capillary diffusion capacity and glucose utilization in the exercising forearm of type 1 (insulin-dependent) diabetic patients.

B L Johansson1, B Linde, J Wahren.   

Abstract

Microvascular dysfunction is frequently seen in patients with Type 1 (insulin-dependent) diabetes. The present study was undertaken to examine whether skeletal muscle microcirculation in Type 1 diabetic patients is influenced by C-peptide. Forearm blood flow, capillary diffusion capacity and substrate exchange were studied during strenuous rhythmic forearm exercise on a hand ergometer. Measurements were made before and during i.v. infusion for 60 min of C-peptide or 0.9% NaCl in Type 1 diabetic patients and healthy subjects. During infusion the C-peptide levels in the diabetic patients increased from less than 0.05 nmol/l to 1.32 +/- 0.08 nmol/l. Prior to infusion forearm blood flow and capillary diffusion capacity during exercise were lower in the diabetic patients than the control subjects. During C-peptide infusion both variables increased in the diabetic patients (blood flow +27 +/- 4%, capillary diffusion capacity +52 +/- 9%) to levels similar to those in the healthy subjects, while no significant change was seen in the healthy control subjects or the diabetic patients given NaCl. Forearm uptake of oxygen and glucose in the diabetic patients increased markedly after C-peptide administration but were unchanged after NaCl infusion. Significant uptake of C-peptide to the deep forearm tissues was observed in the resting state; approximately 7 +/- 2% of the arterial C-peptide concentration was extracted by forearm tissues in diabetic patients as well as in healthy control subjects.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1478367     DOI: 10.1007/bf00401369

Source DB:  PubMed          Journal:  Diabetologia        ISSN: 0012-186X            Impact factor:   10.122


  18 in total

1.  The amount of trapped plasma in a high speed micro-capillary hematocrit centrifuge.

Authors:  L GARBY; J C VUILLE
Journal:  Scand J Clin Lab Invest       Date:  1961       Impact factor: 1.713

Review 2.  Proteolytic processing in the biosynthesis of insulin and other proteins.

Authors:  D F Steiner; W Kemmler; H S Tager; J D Peterson
Journal:  Fed Proc       Date:  1974-10

3.  Biological activity of proinsulin and related polypeptides in the fat tissue.

Authors:  S S Yu; A E Kitbachi
Journal:  J Biol Chem       Date:  1973-06-10       Impact factor: 5.157

4.  Release of peripherally stored insulin during acute muscular work in man.

Authors:  P Dieterle; B Birkner; K H Gmeiner; P Wagner; F Erhardt; J Henner; C Dierterle
Journal:  Horm Metab Res       Date:  1973-09       Impact factor: 2.936

5.  Vitreous fluorophotometry in juvenile diabetics with and without retinopathy in relation to metabolic control: insulin antibodies and c-peptide levels.

Authors:  A Kernell; J Ludvigsson; K Finnström
Journal:  Acta Ophthalmol (Copenh)       Date:  1990-08

Review 6.  Proinsulin and C-peptide: a review.

Authors:  A E Kitabchi
Journal:  Metabolism       Date:  1977-05       Impact factor: 8.694

7.  Radioimmunological determination of human C-peptide in serum.

Authors:  L G Heding
Journal:  Diabetologia       Date:  1975-12       Impact factor: 10.122

8.  Renal and splanchnic exchange of human biosynthetic C-peptide in type 1 (insulin-dependent) diabetes mellitus.

Authors:  S Sjöberg; B L Johansson; J Ostman; J Wahren
Journal:  Diabetologia       Date:  1991-06       Impact factor: 10.122

9.  The biological and immunological properties of pork and beef insulin, proinsulin, and connecting peptides.

Authors:  A E Kitabchi
Journal:  J Clin Invest       Date:  1970-05       Impact factor: 14.808

10.  Residual C-peptide excretion is associated with a better long-term glycemic control and slower progress of retinopathy in type I (insulin-dependent) diabetes mellitus.

Authors:  S Sjöberg; M Gjötterberg; L Berglund; E Möller; J Ostman
Journal:  J Diabet Complications       Date:  1991 Jan-Mar
View more
  36 in total

1.  C-peptide is a bioactive peptide.

Authors:  J Wahren; K Ekberg; H Jörnvall
Journal:  Diabetologia       Date:  2007-01-18       Impact factor: 10.122

2.  Will C-peptide substitution make a difference in combating complications in insulin-deficient diabetes?

Authors:  Anders A F Sima
Journal:  Rev Diabet Stud       Date:  2004-08-10

Review 3.  Prognostic value of endothelial dysfunction in type 1 diabetes mellitus.

Authors:  Ana Marice Ladeia; Raphael Ribeiro Sampaio; Maiara Costa Hita; Luis F Adan
Journal:  World J Diabetes       Date:  2014-10-15

4.  Biological activity of C-peptide on the skin microcirculation in patients with insulin-dependent diabetes mellitus.

Authors:  T Forst; T Kunt; T Pohlmann; K Goitom; M Engelbach; J Beyer; A Pfützner
Journal:  J Clin Invest       Date:  1998-05-15       Impact factor: 14.808

Review 5.  Pathological consequences of C-peptide deficiency in insulin-dependent diabetes mellitus.

Authors:  Ahmad Ghorbani; Reza Shafiee-Nick
Journal:  World J Diabetes       Date:  2015-02-15

6.  C-peptide improves autonomic nerve function in IDDM patients.

Authors:  B L Johansson; K Borg; E Fernqvist-Forbes; T Odergren; S Remahl; J Wahren
Journal:  Diabetologia       Date:  1996-06       Impact factor: 10.122

7.  Proinsulin C-peptide rapidly stimulates mitogen-activated protein kinases in Swiss 3T3 fibroblasts: requirement of protein kinase C, phosphoinositide 3-kinase and pertussis toxin-sensitive G-protein.

Authors:  T Kitamura; K Kimura; B D Jung; K Makondo; S Okamoto; X Cañas; N Sakane; T Yoshida; M Saito
Journal:  Biochem J       Date:  2001-04-01       Impact factor: 3.857

Review 8.  C-peptide: a new potential in the treatment of diabetic nephropathy.

Authors:  J Wahren; K Ekberg; B Samnegård; B L Johansson
Journal:  Curr Diab Rep       Date:  2001-12       Impact factor: 4.810

Review 9.  Proinsulin C-peptide: friend or foe in the development of diabetes-associated complications?

Authors:  Lina Nordquist; M Johansson
Journal:  Vasc Health Risk Manag       Date:  2008

10.  Renal and vascular benefits of C-peptide: Molecular mechanisms of C-peptide action.

Authors:  Lina Nordquist; Fredrik Palm; Bradley T Andresen
Journal:  Biologics       Date:  2008-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.